F. L. Dunn

2.4k total citations · 1 hit paper
46 papers, 1.6k citations indexed

About

F. L. Dunn is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, F. L. Dunn has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in F. L. Dunn's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Management and Research (11 papers) and Diabetes Treatment and Management (7 papers). F. L. Dunn is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Management and Research (11 papers) and Diabetes Treatment and Management (7 papers). F. L. Dunn collaborates with scholars based in United States, Italy and Malaysia. F. L. Dunn's co-authors include Gary L. Robertson, Thomas J. Brennan, Philip Raskin, G.L. Sparschu, V. K. Rowe, Scott M. Grundy, A Pietri, Alex M. DePaoli, Linda S. Higgins and John D. Bagdade and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Ecology.

In The Last Decade

F. L. Dunn

45 papers receiving 1.4k citations

Hit Papers

The Role of Blood Osmolality and Volume in Regulating Vas... 1973 2026 1990 2008 1973 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. L. Dunn United States 19 535 303 287 282 267 46 1.6k
Paul J. Keller Switzerland 27 742 1.4× 285 0.9× 213 0.7× 99 0.4× 144 0.5× 100 2.5k
C.J. Kenyon United Kingdom 23 499 0.9× 295 1.0× 153 0.5× 62 0.2× 188 0.7× 68 1.6k
Richard J. Krieg United States 24 523 1.0× 462 1.5× 122 0.4× 99 0.4× 149 0.6× 102 1.9k
Michel Pugeat France 34 1.6k 3.0× 627 2.1× 272 0.9× 101 0.4× 121 0.5× 82 3.7k
A Germaín Chile 23 166 0.3× 202 0.7× 364 1.3× 84 0.3× 219 0.8× 53 2.3k
B. Blondeau France 25 458 0.9× 668 2.2× 566 2.0× 115 0.4× 140 0.5× 42 2.5k
A. J. Vander United States 18 132 0.2× 260 0.9× 73 0.3× 93 0.3× 150 0.6× 35 1.6k
M. J. Ellis New Zealand 19 324 0.6× 136 0.4× 106 0.4× 111 0.4× 154 0.6× 37 1.1k
Adelina M. Reis Brazil 29 518 1.0× 399 1.3× 95 0.3× 125 0.4× 111 0.4× 101 2.3k
SR Bornstein Germany 24 547 1.0× 347 1.1× 181 0.6× 79 0.3× 42 0.2× 54 1.7k

Countries citing papers authored by F. L. Dunn

Since Specialization
Citations

This map shows the geographic impact of F. L. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. L. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. L. Dunn more than expected).

Fields of papers citing papers by F. L. Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. L. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. L. Dunn. The network helps show where F. L. Dunn may publish in the future.

Co-authorship network of co-authors of F. L. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of F. L. Dunn. A scholar is included among the top collaborators of F. L. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. L. Dunn. F. L. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DePaoli, Alex M., Linda S. Higgins, Robert R. Henry, Christos S. Mantzoros, & F. L. Dunn. (2014). Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?. Diabetes Care. 37(7). 1918–1923. 55 indexed citations
2.
Kelly, Kevin C., et al.. (2011). U500 Regular Insulin use in Insulin-Resistant type 2 Diabetic Veteran Patients. Endocrine Practice. 18(1). 34–38. 18 indexed citations
3.
Vega, Gloria Lena, F. L. Dunn, & Scott M. Grundy. (2011). Effect of Colesevelam Hydrochloride on Glycemia and Insulin Sensitivity in Men With the Metabolic Syndrome. The American Journal of Cardiology. 108(8). 1129–1135. 18 indexed citations
4.
Dunn, F. L., Linda S. Higgins, Jill Fredrickson, & Alex M. DePaoli. (2010). Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes. Journal of Diabetes and its Complications. 25(3). 151–158. 67 indexed citations
5.
Dunn, F. L.. (2010). Management of dyslipidemia in people with type 2 diabetes mellitus. Reviews in Endocrine and Metabolic Disorders. 11(1). 41–51. 31 indexed citations
7.
Bagdade, John D., F. L. Dunn, Robert H. Eckel, & Mary C. Ritter. (1994). Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(12). 1933–1939. 53 indexed citations
8.
Bagdade, John D. & F. L. Dunn. (1992). Effects of Insulin Treatment on Lipoprotein Composition and Function in Patients With IDDM. Diabetes. 41(Supplement_2). 107–110. 15 indexed citations
9.
Dunn, F. L.. (1990). Human behavior and the communicable diseases of childhood.. American Journal of Public Health. 80(2). 141–142. 4 indexed citations
10.
Dunn, F. L.. (1990). Hyperlipidemia in diabetes mellitus. Diabetes/Metabolism Reviews. 6(1). 47–61. 81 indexed citations
11.
Dunn, F. L.. (1988). Treatment of Lipid Disorders in Diabetes Mellitus. Medical Clinics of North America. 72(6). 1379–1398. 16 indexed citations
12.
Carroll, Patricia B., et al.. (1986). Diet-Induced Essential Fatty Acid Deficiency in Ambulatory Patient With Type I Diabetes Mellitus. Diabetes Care. 9(3). 291–293. 8 indexed citations
13.
Dunn, F. L.. (1982). Hyperlipidemia and Diabetes. Medical Clinics of North America. 66(6). 1347–1360. 40 indexed citations
15.
Sparschu, G.L., et al.. (1971). Study of the effects of high levels of 2,4,5-trichlorophenoxyacetic acid on foetal development in the rat. Food and Cosmetics Toxicology. 9(4). 527–530. 25 indexed citations
16.
Dunn, F. L.. (1964). Odeningotrema apidion n.sp. (Trematoda: Lecithodendriidae) from a Malayan primitive primate.. Proceedings of the Helminthological Society of Washington. 31(1). 21–25. 2 indexed citations
17.
Dunn, F. L.. (1963). A new trichostrongylid nematode from an oriental primate.. Proceedings of the Helminthological Society of Washington. 30(2). 161–165. 4 indexed citations
18.
Dunn, F. L., et al.. (1963). Trypanosomes of South American Monkeys and Marmosets. American Journal of Tropical Medicine and Hygiene. 12(4). 524–534. 38 indexed citations
19.
Dunn, F. L., et al.. (1963). Plasmodium SandoshamiSP. Nov., a New Species of Malaria Parasite from the Malayan Flying Lemur. Annals of Tropical Medicine and Parasitology. 57(1). 75–81. 3 indexed citations
20.
Dunn, F. L.. (1962). Raillietina (R.) trinitatae (Cameron and Reesal, 1951), Baer and Sandars, 1956 (Cestoda) from a Peruvian primate.. Proceedings of the Helminthological Society of Washington. 29(2). 148–152. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026